Weifang Tang

6PUBLICATIONS
8CO-AUTHORS
Biologically active moleculesBiomolecular modelling and designCheminformatics and quantitative structure-activity relationshipsOrganometallic chemistryMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jul 01, 2026
Small Molecules in Development for the Treatment of Sepsis: Insights into Drug Targets and Molecular Mechanisms.

|Apr 02, 2024
Design, Synthesis, and Biological Evaluation of a Novel NIK Inhibitor with Anti-Inflammatory and Hepatoprotective Effects for Sepsis Treatment.

Nanxia Zhang, Shige Shen, Mengyu Yang

|Sep 22, 2021
Discovery of a Potent FLT3 Inhibitor (LT-850-166) with the Capacity of Overcoming a Variety of FLT3 Mutations.

Zhijie Wang, Jiongheng Cai, Jiwei Ren

|Aug 20, 2021
Discovery of N-(4-(3-isopropyl-2-methyl-2H-indazol-5-yl)pyrimidin-2-yl)-4-(4-methylpiperazin-1-yl)quinazolin-7-amine as a Novel, Potent, and Oral Cyclin-Dependent Kinase Inhibitor against Haematological Malignancies.

Jianhang Huang, Xinren Wang, Ruinan Dong

|Nov 23, 2019
Redox-Neutral Borylation of Aryl Sulfonium Salts via C-S Activation Enabled by Light.

Chen Huang, Jie Feng, Rui Ma

|May 10, 2017
Potent Pan-Raf and Receptor Tyrosine Kinase Inhibitors Based on a Cyclopropyl Formamide Fragment Overcome Resistance.

Yanmin Zhang, Lu Wang, Qing Zhang

Pageof 1

Frequent Collaborators

4 joint publications

Yadong Chen

2 joint publications

Nanxia Zhang

1 joint publications

Jie Feng

1 joint publications

Ding Du